Sales rise 598.38% to Rs 392.56 crore
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024 as against net loss of Rs 130.16 crore during the previous quarter ended December 2023. Sales rose 598.38% to Rs 392.56 crore in the quarter ended December 2024 as against Rs 56.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales392.5656.21 598 OPM %36.48-18.68 -PBDT102.78-35.36 LP PBT34.02-54.88 LP NP-68.85-130.16 47Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
